Added to YB: 2024-07-08
Pitch date: 2024-07-08
LTP:AU [bullish]
LTR Pharma Limited
-33.91%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia.
Market Cap
AUD 101.8M
Pitch Price
AUD 0.87
Price Target
N/A
Dividend
N/A
EV/EBITDA
-7.57
P/E
-11.34
EV/Sales
67.18
Sector
Pharmaceuticals
Category
N/A
Show full summary:
LTR Pharma Limited LTP:AU
A summary for this pitch has not been created yet.
Read full article (0 min)